Pancreatic Cancer Research

ResearcherUniversity of ManchesterNo recent work listed

Rille Pihlak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6055-334X; OpenAlex author ID A5023644998. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers15030738↗
  2. Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemothera… Co-author DOI 10.1080/0284186x.2022.2053198↗
  3. Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice. Co-author DOI 10.4251/wjgo.v11.i2.102↗
  4. The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.currproblcancer.2018.01.013↗
  5. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment? Co-author DOI 10.1016/j.ejso.2018.07.047↗
  6. Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy. Co-author DOI 10.3390/cancers10010017↗
  7. Germline mutations in pancreatic cancer and potential new therapeutic options. Co-author DOI 10.18632/oncotarget.17291↗
  8. Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/ijms18050909↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mairead Geraldine McNamara · 8 shared papers, 2017–2023 · strength 0.94
  2. Juan W. Valle · 7 shared papers, 2017–2023 · strength 0.80
  3. Ángela Lamarca Lete · 4 shared papers, 2017–2023 · strength 0.48
  4. Richard A Hubner · 4 shared papers, 2017–2023 · strength 0.48
  5. Derek A O'Reilly · 2 shared papers, 2018–2019 · strength 0.18
  6. Alexandra R. Lewis · 1 shared paper, 2018 · strength 0.14
  7. Alan Anthoney · 1 shared paper, 2022 · strength 0.13
  8. George Papaxoinis · 1 shared paper, 2022 · strength 0.13
  9. Konstantinos Vellios Kamposioras · 1 shared paper, 2022 · strength 0.13
  10. Nicola de Liguori Carino · 1 shared paper, 2018 · strength 0.09
  11. Ajith Kumar Siriwardena · 1 shared paper, 2018 · strength 0.09
  12. Ganesh Radhakrishna · 1 shared paper, 2018 · strength 0.09
  13. Alexander Fulton · 1 shared paper, 2019 · strength 0.09
  14. Jaseela Chiramel · 1 shared paper, 2017 · strength 0.07
  15. Eitan Amir · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.